New approaches to graft engineering for haploidentical bone marrow transplantation

Seminars in Oncology

Volumn 39, Issue 6, 2012, Pages 664-673

  Handgretinger, Rupert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE TRANSFER; ADULT; BIOENGINEERING; BONE MARROW; BONE MARROW TRANSPLANTATION; CD19+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD34 SELECTION; CD4+ CD25+ T LYMPHOCYTE; CELL SELECTION; CHILD; DRUG MEGADOSE; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL TRANSPLANTATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HLA MATCHING; HUMAN; IMMUNE SYSTEM; LEUKEMIA; MAGNETIC CELL SORTING; MEDICAL DEVICE; MEDICAL TECHNOLOGY; MORTALITY; NATURAL KILLER CELL; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL MOBILIZATION; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

EID: 84870701844     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.09.007     Document Type: Article

References (71)

1. P.G. Beatty, K.M. Boucher, M. Mori, E.L. Milford Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors Hum Immunol 61 2000 834 840
2. M.B. Heemskerk, S.M. van Walraven, J.J. Cornelissen How to improve the search for an unrelated haematopoietic stem cell donor Faster is better than more! Bone Marrow Transplant 35 2005 645 652
3. D.P. Lu, L. Dong, T. Wu Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation Blood 107 2006 3065 3073
4. L. Luznik, P.V. O'Donnell, H.J. Symons HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide Biol Blood Marrow Transplant 14 2008 641 650
5. R.L. Powles, G.R. Morgenstern, H.E. Kay Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia Lancet 1 1983 612 615
6. Y. Reisner, N. Kapoor, D. Kirkpatrick Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 61 1983 341 348
7. W. Friedrich, S.F. Goldmann, U. Vetter Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow Lancet 1 1984 761 764
8. N.A. Kernan, N. Flomenberg, B. Dupont, R.J. O'Reilly Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia Identification of host-derived antidonor allocytotoxic T lymphocytes Transplantation 43 1987 842 847
9. J. Mehta, S. Singhal, A.P. Gee Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients Bone Marrow Transplant 33 2004 389 396
10. E. Bachar-Lustig, N. Rachamim, H.W. Li, F. Lan, Y. Reisner Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med 1 1995 1268 1273
11. F. Aversa, A. Tabilio, A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
12. + hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation Exp Hematol 23 1995 320 322
13. + progenitors for autologous and allogeneic transplantation in children Bone Marrow Transplant 24 1999 583 589
14. + cells using the CliniMACS device J Hematother 8 1999 209 218
15. + ) progenitor cells from HLA-mismatched parental donors in children Bone Marrow Transplant 27 2001 777 783
16. P. Lang, J. Greil, P. Bader Long-term outcome after haploidentical stem cell transplantation in children Blood Cells Mol Dis 33 2004 281 287
17. F. Locatelli, D. Pende, R. Maccario, M.C. Mingari, A. Moretta, L. Moretta Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference Clin Immunol 133 2009 171 178
18. T. Klingebiel, J. Cornish, M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group Blood 115 2010 3437 3446
19. F. Aversa, A. Terenzi, A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
20. F. Aversa, Y. Reisner, M.F. Martelli The haploidentical option for high-risk haematological malignancies Blood Cells Mol Dis 40 2008 8 12
21. + cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment Leukemia 13 1999 2070 2078
22. L. Ruggeri, M. Capanni, E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
23. P.R. Gordon, T. Leimig, I. Mueller A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells Bone Marrow Transplant 30 2002 69 74
24. G.A. Hale, K.A. Kasow, K. Gan Haploidentical stem cell transplantation with CD3 depleted mobilized peripheral blood stem cell grafts for children with hematologic malignancies Blood (Meeting Abstracts) 106 2005 2910
25. G.A. Hale, K.A. Kasow, R. Madden Mismatched family member donor transplantation for patients with refractory hematologic malignancies: long-term followup of a prospective clinical trial Blood (Meeting Abstracts) 108 2006 3137
26. X. Chen, G.A. Hale, R. Barfield Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies Br J Haematol 135 2006 524 532
27. R.C. Barfield, M. Otto, J. Houston A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation Cytotherapy 6 2004 1 6
28. R. Handgretinger, X. Chen, M. Pfeiffer Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation Ann NY Acad Sci 1106 2007 279 289
29. P. Lang, I. Mueller, J. Greil Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients Blood Cells Mol Dis 40 2008 33 39
30. M.M. Pfeiffer, T. Feuchtinger, H.M. Teltschik Reconstitution of NK cell receptors influences NK activity and relapse rate after haploidentical transplantation of T and B cell depleted grafts in children Haematologica 95 2010 1381 1388
31. P. Bader, J. Soerensen, A. Jarisch Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells Best Pract Res Clin Haematol 24 2011 331 337
32. G. Dufort, S. Pisano, A. Incoronato Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay Bone Marrow Transplant 47 2011 663 668
33. J. Palma, L. Salas, F. Carrion Haploidentical stem cell transplantation for children with high-risk leukemia Pediatr Blood Cancer 59 2012 895 901
34. W. Leung, D. Campana, J. Yang High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia Blood 118 2011 223 230
35. B. Federmann, M. Hagele, M. Pfeiffer Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts Leukemia 25 2011 121 129
36. B. Federmann, M. Bornhauser, C. Meisner Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study Haematologica 97 2012 1523 1531
37. S. Chaleff, M. Otto, R.C. Barfield A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation Cytotherapy 9 2007 746 754
38. M. Bonneville, R.L. O'Brien, W.K. Born Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity Nat Rev Immunol 10 2010 467 478
39. S. Chiplunkar, S. Dhar, D. Wesch, D. Kabelitz gammadelta T cells in cancer immunotherapy: current status and future prospects Immunotherapy 1 2009 663 678
40. R. Handgretinger, P. Lang, T.F. Feuchtinger Transplantation of TcRαβ/CD19 depleted stem cells from haploidentical donors: robust engraftment and rapid immune reconstitution in children with high risk leukemia Blood (Meeting Abstracts) 118 2011 1005
41. K.T. Godder, P.J. Henslee-Downey, J. Mehta Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation Bone Marrow Transplant 39 2007 751 757
42. X. Chen, R. Barfield, E. Benaim Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients Blood 105 2005 886 893
43. A. Velardi, L. Ruggeri, A. Mancusi, F. Aversa, F.T. Christiansen Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia Curr Opin Immunol 21 2009 525 530
44. W. Leung Use of NK cell activity in cure by transplant Br J Haematol 155 2011 14 29
45. A. Velardi Role of KIRs and KIR ligands in hematopoietic transplantation Curr Opin Immunol 20 2008 581 587
46. M.M. Pfeiffer, T. Feuchtinger, H.M. Teltschik Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children Haematologica 95 2010 1381 1388
47. M. Stern, A.C. de, E. Urbani Natural killer-cell KIR repertoire reconstitution after haploidentical SCT Bone Marrow Transplant 45 2010 1607 1610
48. E.J. Lowe, V. Turner, R. Handgretinger T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation Br J Haematol 123 2003 323 326
49. X.J. Huang, X.Y. Zhao, D.H. Liu, K.Y. Liu, L.P. Xu Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion Leukemia 21 2007 848 851
50. S. Cooley, D.J. Weisdorf, L.A. Guethlein Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia Blood 116 2010 2411 2419
51. L. Oevermann, S. Michaelis, M. Mezger Reduced risk of relapse in pediatric ALL after haploidentical transplantation of T-cell depleted grafts from KIR haplotype B donors Blood (Meeting Abstracts) 118 2011 4133
52. R. Iyengar, R. Handgretinger, A. Babarin-Dorner Purification of human natural killer cells using a clinical-scale immunomagnetic method Cytotherapy 5 2003 479 484
53. W. Leung, R. Iyengar, T. Leimig, M.S. Holladay, J. Houston, R. Handgretinger Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method Cancer Immunol Immunother 54 2005 389 394
54. J. Shi, G. Tricot, S. Szmania Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation Br J Haematol 143 2008 641 653
55. J.R. Passweg, A. Tichelli, S. Meyer-Monard Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation Leukemia 18 2004 1835 1838
56. J.E. Rubnitz, H. Inaba, R.C. Ribeiro NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia J Clin Oncol 28 2010 955 959
57. L. Pfeiffer, M. Schumm, I. Mueller, T. Feuchtinger, R. Handgretinger IL-15 activated CD3/19 depleted grafts for haploidentical transplantation in children: strongly increased NK activity in vitro and excellent tolerability in vivo Bone Marrow Transplant (Meeting Abstracts) 41 2008 51
58. J.S. Miller, Y. Soignier, A. Panoskaltsis-Mortari Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 2005 3051 3057
59. R. Seggewiss, H. Einsele Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update Blood 115 2010 3861 3868
60. Y. Kang, N.J. Chao, F. Aversa Unmanipulated or CD34 selected haplotype mismatched transplants Curr Opin Hematol 15 2008 561 567
61. C. Becker, H. Pohla, B. Frankenberger Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay Nat Med 7 2001 1159 1162
62. + T cells according to IFN-gamma secretion for adjuvant immunotherapy Exp Hematol 32 2004 282 289
63. + ) T cells based on cytokine secretion Eur J Immunol 29 1999 4053 4059
64. T. Feuchtinger, S. Matthes-Martin, C. Richard Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation Br J Haematol 134 2006 64 76
65. T. Feuchtinger, K. Opherk, W.A. Bethge Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation Blood 116 2010 4360 4367
66. Icheva V, Kayser S, Wolff D, et al. Adoptive transfer of EBNA1-specific T cells as a treatment of Epstein-Barr-virus reactivation and lymphoproliferative disorders following allogeneic stem cell transplantation. J Clin Oncol. In press.
67. J. Yao, C. Bechter, M. Wiesneth Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study Clin Infect Dis 46 2008 e96 e105
68. + T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation Transfusion 51 2011 591 599
69. + regulatory T cells with potent suppressor activity J Immunol Methods 315 2006 27 36
70. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 2003 1144 1150
71. M. Di Ianni, F. Falzetti, A. Carotti Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928